Back to Hudson Bay Capital Management LP Hudson Bay Capital Management LP

ANTXANTX

2 quarters

Position history for Hudson Bay Capital Management LPHudson Bay Capital Management LP's holdings in AN2 THERAPEUTICS INC

No. Hudson Bay Capital Management exited its ANTX (AN2 Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 34,605 shares worth $118,349. Hudson Bay Capital Management first reported ANTX in Q1 2026 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$118,349

Total Shares Change

-34,605

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$4.84
0
2026-Q1
New
34,605
—
$118,3490.0%$1.06
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used